...
apge-img

Apogee Therapeutics, Inc. Common Stock, Common Stock

APGE

NMQ

$49.07

-$0.9

(-1.8%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.84B
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
334.80K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
0
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$20.78 L
$72.29 H
$49.07

About Apogee Therapeutics, Inc. Common Stock, Common Stock

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), asthma, chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs comprise APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. Apogee Therapeutics, Inc. was incorporated in 2022 and is headquartered in Waltham, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameAPGESectorS&P500
1-Week Return6.35%-1.95%0.69%
1-Month Return-18.84%-3.36%1.53%
3-Month Return3.28%-6.93%11.27%
6-Month Return11.78%-1.83%13.49%
1-Year Return135.46%8.53%31.62%
3-Year Return188.65%7.58%30.33%

Financials

Dec '22Dec '23
Total Revenue--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Profit--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Gross Margin--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Operating Expenses30.73M93.00M[{"date":"2022-12-31","value":33.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Operating Income(30.73M)(93.00M)[{"date":"2022-12-31","value":-3072700000,"profit":false},{"date":"2023-12-31","value":-9300300000,"profit":false}]
Total Non-Operating Income/Expense(18.12M)18.04M[{"date":"2022-12-31","value":-100.44,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Pre-Tax Income(39.78M)(83.98M)[{"date":"2022-12-31","value":-3978500000,"profit":false},{"date":"2023-12-31","value":-8398500000,"profit":false}]
Income Taxes(33.52K)(93.00K)[{"date":"2022-12-31","value":-3352000,"profit":false},{"date":"2023-12-31","value":-9300300,"profit":false}]
Income After Taxes(39.75M)(83.89M)[{"date":"2022-12-31","value":-3975148000,"profit":false},{"date":"2023-12-31","value":-8389199700,"profit":false}]
Income From Continuous Operations(39.78M)(83.98M)[{"date":"2022-12-31","value":-3978500000,"profit":false},{"date":"2023-12-31","value":-8398500000,"profit":false}]
Income From Discontinued Operations--[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(39.78M)(83.98M)[{"date":"2022-12-31","value":-3978500000,"profit":false},{"date":"2023-12-31","value":-8398500000,"profit":false}]
EPS (Diluted)-(6.99)[{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":-699,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

APGE
Cash Ratio 16.13
Current Ratio 16.39

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

APGE
ROA (LTM) -18.52%
ROE (LTM) -25.65%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

APGE
Debt Ratio Lower is generally better. Negative is bad. 0.05
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.95

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

APGE
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 3.87
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Apogee Therapeutics, Inc. Common Stock share price today?

Apogee Therapeutics, Inc. Common Stock (APGE) share price today is $49.07

Can Indians buy Apogee Therapeutics, Inc. Common Stock shares?

Yes, Indians can buy shares of Apogee Therapeutics, Inc. Common Stock (APGE) on Vested. To buy Apogee Therapeutics, Inc. Common Stock from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in APGE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Apogee Therapeutics, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Apogee Therapeutics, Inc. Common Stock (APGE) via the Vested app. You can start investing in Apogee Therapeutics, Inc. Common Stock (APGE) with a minimum investment of $1.

How to invest in Apogee Therapeutics, Inc. Common Stock shares from India?

You can invest in shares of Apogee Therapeutics, Inc. Common Stock (APGE) via Vested in three simple steps:

  • Click on Sign Up or Invest in APGE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Apogee Therapeutics, Inc. Common Stock shares
What is Apogee Therapeutics, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Apogee Therapeutics, Inc. Common Stock (APGE) is $72.29. The 52-week low price of Apogee Therapeutics, Inc. Common Stock (APGE) is $20.78.

What is Apogee Therapeutics, Inc. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Apogee Therapeutics, Inc. Common Stock (APGE) is

What is Apogee Therapeutics, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Apogee Therapeutics, Inc. Common Stock (APGE) is 3.87

What is Apogee Therapeutics, Inc. Common Stock dividend yield?

The dividend yield of Apogee Therapeutics, Inc. Common Stock (APGE) is 0.00%

What is the Market Cap of Apogee Therapeutics, Inc. Common Stock?

The market capitalization of Apogee Therapeutics, Inc. Common Stock (APGE) is $2.84B

What is Apogee Therapeutics, Inc. Common Stock’s stock symbol?

The stock symbol (or ticker) of Apogee Therapeutics, Inc. Common Stock is APGE

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top